Delivery Order SPE2DB22D3016-SPE2DB23FAZD7
- Not listed
- This federal contract award, valued at $10,291.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4560819661 - Otezla 30 mg tablets. The contract has an ultimate completion date of May 4, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract is a Delivery Order valued at $2,600.43 with a completion date of November 17, 2023. It is a Firm Fixed Price contract for the purchase of Otezla 30 mg Tablets. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,363.89 firm-fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of July 18, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,564,146,007 units of Otezla 30 mg tablets. The contract, valued at $18,980.17, is a firm fixed-price delivery order with an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Otezla 30 mg tablets (60s) to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The $7,807.93 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
- This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $4,900.52 delivery order is for the pharmaceutical product Otezla 30mg Tablet 60s. The contract is a firm fixed-price Delivery Order with an ultimate completion date of April 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,816.06 firm-fixed-price delivery order is for Otezla 30 mg tablets, a specialty medication. The contract has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,957.45 delivery order contract is for the supply of OTEZLA 30 MG TABLET 60S, a medication, and has a firm fixed price. The contract has an ultimate completion date of May 31, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that runs...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,251.60 firm fixed-price delivery order is for the supply of OTEZLA 30 MG TABLET 60S, a specialty medication. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,761.82 firm fixed price delivery order is for the supply of OTEZLA 30 MG TAB 60S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB23FAZD7Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,069.09 firm-fixed-price delivery order is for the supply of Otezla 30 mg tablets. The contract has an ultimate completion date of April 25, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract was awarded through full and open competition without any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 4/24/23 |